chemistry

Ibrilatazar

Ibrilatazar is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Ibrilatazar rather than just read about it. In short: Ibrilatazar also known as α-hydroxylinoleic acid is a small-molecule, experimental cancer drug being developed by Ability Pharmaceuticals. History In 2015, Ability announced that it had received orphan drug designation (ODD) for pediatric cancer neuroblastoma from the European Medical Agency (EMA) and the US Food and Drug Administration (FDA).

Key takeaways

Ibrilatazar belongs to chemistry; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Ibrilatazar to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Ibrilatazar from memory before moving on to harder problems.

Reference excerpt

Ibrilatazar also known as α-hydroxylinoleic acid is a small-molecule, experimental cancer drug being developed by Ability Pharmaceuticals.

History In 2015, Ability announced that it had received orphan drug designation (ODD) for pediatric cancer neuroblastoma from the European Medical Agency (EMA) and the US Food and Drug Administration (FDA). Also in 2016 a preclinical study confirmed that ABTL0812 was well tolerated. In December 2016 the company announced Ibrilatazar has received an Orphan Drug Designation for the treatment of pancreatic cancer.

Mechanism of action One mechanism of action is the activation of the PPAR-alpha and PPAR-gamma receptors which in turn up-regulate the expression of the TRIB3 gene, leading to inhibition of the PI3K/AKT/mTOR pathway. This pathway is excessively activated in most human cancers, supporting tumor growth. It is a principal target of various new anti-tumour drugs. Tumor cells are killed via autophagic cell death, rather than apoptosis. ABTL0812 activates the PPAR receptors, inducing TRIB3 over-expression. TRIB3 binds to the Akt oncogene and inhibits the Akt/mTOR axis.

Clinical trials ABTL0812 showed efficacy in Phase I clinical trials in patients with advanced cancer, with low toxicity and high tolerability.

References

Illustrations

Worked examples

Example 1 — a first encounter with Ibrilatazar

Start with the simplest possible case. Write down what Ibrilatazar claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Ibrilatazar before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Ibrilatazar ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Ibrilatazar

In research: Ibrilatazar appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Ibrilatazar in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Ibrilatazar is common in secondary-school and first-year university syllabi. It links to neighbouring topics Alpha hydroxycarboxylic acids, Experimental cancer drugs, Fatty acids, so understanding it makes those chapters shorter.
In everyday life: Look for Ibrilatazar outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Ibrilatazar” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Ibrilatazar in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Ibrilatazar means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Ibrilatazar out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Ibrilatazar in simple terms?

Ibrilatazar also known as α-hydroxylinoleic acid is a small-molecule, experimental cancer drug being developed by Ability Pharmaceuticals. History In 2015, Ability announced that it had received orphan drug designation (ODD) for pediatric cancer neuroblastoma from the European Medical Agency (EMA)…

Why does Ibrilatazar matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Ibrilatazar?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Ibrilatazar.